Literature DB >> 17066428

Health systems in East Asia: what can developing countries learn from Japan and the Asian Tigers?

Adam Wagstaff1.   

Abstract

The health systems of Japan and the Asian Tigers (Hong Kong, Korea, Singapore and Taiwan), and the recent reforms to them, provide many potentially valuable lessons to East Asia's developing countries. All five systems have managed to keep a check on health spending despite their different approaches to financing and delivery. These differences are reflected in the progressivity of health finance, but the precise degree of progressivity of individual sources and the extent to which households are vulnerable to catastrophic health payments depend on the design features of the system - the height of any ceilings on social insurance contributions, the fraction of health spending covered by the benefit package, the extent to which the poor face reduced copayments, whether there are caps on copayments, and so on. On the delivery side, too, Japan and the Tigers offer some interesting lessons. Singapore's experience with corporatizing public hospitals - rapid cost and price inflation, a race for the best technology, and so on - illustrates the difficulties of corporatization. Korea's experience with a narrow benefit package illustrates the danger of providers shifting demand from insured services with regulated prices to uninsured services with unregulated prices. Japan, in its approach to rate setting for insured services, has managed to combine careful cost control with fine-tuning of profit margins on different types of care. Experiences with DRGs in Korea and Taiwan point to cost-savings but also to possible knock-on effects on service volume and total health spending. Korea and Taiwan both offer important lessons for the separation of prescribing and dispensing, including the risks of compensation costs outweighing the cost savings caused by more 'rational' prescribing, and cost-savings never being realized because of other concessions to providers, such as allowing them to have onsite pharmacists. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17066428     DOI: 10.1002/hec.1180

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  5 in total

Review 1.  Can questions of the privatization and corporatization, and the autonomy and accountability of public hospitals, ever be resolved?

Authors:  Jeffrey Braithwaite; Joanne F Travaglia; Angus Corbett
Journal:  Health Care Anal       Date:  2011-06

2.  Regulated medical fee schedule of the Japanese health care system.

Authors:  Makoto Kakinaka; Ryuta Ray Kato
Journal:  Int J Health Care Finance Econ       Date:  2013-09-26

3.  Health benefits of reduced patient cost sharing in Japan.

Authors:  Akihiro Nishi; J Michael McWilliams; Haruko Noguchi; Hideki Hashimoto; Nanako Tamiya; Ichiro Kawachi
Journal:  Bull World Health Organ       Date:  2012-02-12       Impact factor: 9.408

4.  Impact of Catastrophic Health Expenditures on Chinese Household Consumption.

Authors:  Ning Wei; Wenhao Huang; Lü-Lin Zhou
Journal:  Front Public Health       Date:  2021-11-10

5.  Associations of Chinese diagnosis-related group systems with inpatient expenditures for older people with hip fracture.

Authors:  Zhaolin Meng; Kun Zou; Suhang Song; Huazhang Wu; Youli Han
Journal:  BMC Geriatr       Date:  2022-03-01       Impact factor: 3.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.